Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Grifols SA (NASDAQ:GRFS)

32.45
Delayed Data
As of Jul 31
 -0.45 / -1.37%
Today’s Change
29.24
Today|||52-Week Range
40.48
-4.53%
Year-to-Date
No recent news for Grifols SA.

Today’s Trading

Previous close32.90
Today’s open32.89
Day’s range32.35 - 32.93
Volume361,568
Average volume (3 months)374,876
Market cap$4.2B
Dividend yield2.01%
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+34.74%
Earnings growth (this year)--
Earnings growth (next 5 years)+11.50%
Revenue growth (last year)+21.57%
P/E ratio--
Price/Sales2.63
Price/Book3.45

Competitors

 Today’s
change
Today’s
% change
NBIXNeurocrine Bioscienc...+0.10+0.20%
RAREUltragenyx Pharmaceu...+5.11+4.41%
ACADACADIA Pharmaceutica...+0.99+2.07%
IPXLImpax Laboratories I...+0.10+0.21%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateOctober 28, 2015
EPS forecast (this quarter)$0.46
Annual revenue (last year)$4.4B
Annual profit (last year)$621.4M
Net profit margin14.01%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Víctor Grifols Roura
Chief Financial Officer &
Vice President
Alfredo Arroyo Guerra
Corporate headquarters
Barcelona, Catalonia

Forecasts